ChoA Pharmaceutical Co.Ltd (KQ:034940) — Market Cap & Net Worth
Market Cap & Net Worth: ChoA Pharmaceutical Co.Ltd (034940)
ChoA Pharmaceutical Co.Ltd (KQ:034940) has a market capitalization of $19.32 Million (₩28.50 Billion) as of May 4, 2026. Listed on the KQ stock exchange, this Korea-based company holds position #25127 globally and #1866 in its home market, demonstrating a -3.56% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying ChoA Pharmaceutical Co.Ltd's stock price ₩920.00 by its total outstanding shares 30979827 (30.98 Million). Analyse ChoA Pharmaceutical Co.Ltd operating cash flow efficiency to see how efficiently the company converts income to cash.
ChoA Pharmaceutical Co.Ltd Market Cap History: 2015 to 2026
ChoA Pharmaceutical Co.Ltd's market capitalization history from 2015 to 2026. Data shows change from $92.80 Million to $19.32 Million (-13.77% CAGR).
Index Memberships
ChoA Pharmaceutical Co.Ltd is a constituent of 2 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
Kosdaq Composite Index
KOSDAQ
|
$299.07 Billion | 0.01% | #1010 of 1384 |
|
Kosdaq Composite Index
KQ11
|
$299.07 Billion | 0.01% | #1010 of 1384 |
Weight: ChoA Pharmaceutical Co.Ltd's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
ChoA Pharmaceutical Co.Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how ChoA Pharmaceutical Co.Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.00x
ChoA Pharmaceutical Co.Ltd's market cap is 0.00 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $97.20 Million | $55.55 Billion | $163.17 Million | 0.00x | 0.60x |
| 2017 | $97.31 Million | $58.87 Billion | $1.62 Billion | 0.00x | 0.06x |
| 2018 | $91.64 Million | $63.09 Billion | $641.15 Million | 0.00x | 0.14x |
| 2019 | $79.36 Million | $67.54 Billion | -$905.31 Million | 0.00x | N/A |
| 2020 | $104.55 Million | $65.36 Billion | -$1.32 Billion | 0.00x | N/A |
| 2021 | $78.94 Million | $57.56 Billion | -$8.04 Billion | 0.00x | N/A |
| 2022 | $49.44 Million | $68.88 Billion | $560.69 Million | 0.00x | 0.09x |
| 2023 | $41.59 Million | $62.97 Billion | -$10.51 Billion | 0.00x | N/A |
| 2024 | $20.55 Million | $62.69 Billion | -$9.60 Billion | 0.00x | N/A |
| 2025 | $21.20 Million | $59.31 Billion | -$6.81 Billion | 0.00x | N/A |
Competitor Companies of 034940 by Market Capitalization
Companies near ChoA Pharmaceutical Co.Ltd in the global market cap rankings as of May 4, 2026.
Key companies related to ChoA Pharmaceutical Co.Ltd by market ranking:
- Takeda Pharmaceutical Co Ltd ADR (NYSE:TAK): Ranked #499 globally with a market cap of $52.60 Billion USD.
- Zoetis Inc (NYSE:ZTS): Ranked #525 globally with a market cap of $50.31 Billion USD.
- Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #526 globally with a market cap of $50.29 Billion USD ( CN¥343.70 Billion CNY).
- GALDERMA GROUP AG (NYSE:GALDY): Ranked #572 globally with a market cap of $45.88 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #499 | Takeda Pharmaceutical Co Ltd ADR | NYSE:TAK | $52.60 Billion | $16.65 |
| #525 | Zoetis Inc | NYSE:ZTS | $50.31 Billion | $114.16 |
| #526 | Jiangsu Hengrui Medicine Co Ltd | SHG:600276 | $50.29 Billion | CN¥53.88 |
| #572 | GALDERMA GROUP AG | NYSE:GALDY | $45.88 Billion | $42.15 |
ChoA Pharmaceutical Co.Ltd Historical Marketcap From 2015 to 2026
Between 2015 and today, ChoA Pharmaceutical Co.Ltd's market cap moved from $92.80 Million to $ 19.32 Million, with a yearly change of -13.77%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | ₩19.32 Million | -8.91% |
| 2025 | ₩21.20 Million | +3.17% |
| 2024 | ₩20.55 Million | -50.58% |
| 2023 | ₩41.59 Million | -15.88% |
| 2022 | ₩49.44 Million | -37.37% |
| 2021 | ₩78.94 Million | -24.50% |
| 2020 | ₩104.55 Million | +31.75% |
| 2019 | ₩79.36 Million | -13.40% |
| 2018 | ₩91.64 Million | -5.83% |
| 2017 | ₩97.31 Million | +0.11% |
| 2016 | ₩97.20 Million | +4.75% |
| 2015 | ₩92.80 Million | -- |
End of Day Market Cap According to Different Sources
On May 4th, 2026 the market cap of ChoA Pharmaceutical Co.Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $19.32 Million USD |
| MoneyControl | $19.32 Million USD |
| MarketWatch | $19.32 Million USD |
| marketcap.company | $19.32 Million USD |
| Reuters | $19.32 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About ChoA Pharmaceutical Co.Ltd
ChoA Pharmaceutical Co., Ltd. operates as a pharmaceutical company in South Korea. The company produces approximately 200 medicines and health foods, including 30 internal ampoule products, such as Hepos, Fematin, Vasoclean, Mabis, etc. Its products include drugs for digestive, circulatory, and respiratory systems; vitamins, minerals, and nutrients; anti inflammation and analgesics; peripheral ne… Read more